课题基金 / 基金详情

项目摘要

项目成果

ROBERT J LINHARDT的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):该提案要求部分支持将于2010年7月11日至16日在新罕布什尔州安多弗普罗克特学院举行的戈登蛋白聚糖研究会议。该会议自1984年以来每两年举行一次,享有盛誉。它汇集了一群不同的研究人员,他们将在紧张而非正式的环境中提出新的和未发表的对蛋白多糖的高影响研究。会议将由科学组织委员会选择的特邀演讲者组成,该委员会包括前蛋白多糖戈登会议主席和其他具有大量蛋白多糖研究专业知识的人。除了召集高水平的蛋白多糖研究科学家之外,会议还为新的研究人员提供了一个论坛,他们可以在海报会议上展示他们的工作,或者在某些情况下,作为受邀演讲者,在受邀演讲者的核心集合之间进行简短的演讲。戈登会议设置为所有与会者提供了一个独特而有效的方式来密切互动。广泛的讨论以及精心组织的田园环境为与会者提供了充分的机会与演讲者直接互动,这样他们就可以获得最新研究成果的额外见解,同时促进新的合作的形成。蛋白聚糖领域以其合作、公开讨论和对初级研究者的支持而闻名。最初会议主要关注软骨和关节炎。然而,随着时间的推移,人们越来越清楚地认识到蛋白聚糖在许多生物系统中具有关键功能,包括肌肉骨骼系统的许多部分的形成和病理,如肌肉、骨骼、肌腱和牙齿。除了在骨骼中的功能外,蛋白聚糖在免疫学和炎症、血管化、心脏功能、癌症和发育中也起着重要作用。蛋白多糖在这些系统中的作用为设计治疗与之相关的常见疾病的疗法提供了重要的基础,这些研究领域将是本次会议的重点。蛋白聚糖也被证明在罕见疾病中发挥关键作用,如多发性遗传性外生骨瘤和粘多糖病,这两种疾病都将在该计划中得到强调。今年将增加两个新的会议,讨论蛋白聚糖在干细胞生物学、组织工程和再生医学(TERM)中的作用。蛋白多糖会议非常国际化,超过40%的与会者来自欧洲、亚洲、南美和澳大利亚。与会者将从在线提交的申请中被邀请,并将被选中代表不同的研究人员,并将在会议的各个方面,包括讨论领袖,演讲者,海报展示者和与会者,仔细关注妇女和代表性不足的少数民族。
英文摘要
DESCRIPTION (provided by applicant): The proposal requests partial support for the Gordon Research Conference on Proteoglycans that will be held on July 11-16, 2010 in Proctor Academy, Andover, NH. The conference has been held every two years since 1984 and has an outstanding reputation. It brings together a diverse group of investigators who will present new and unpublished high impact research on proteoglycans in an intense yet informal setting. The conference will be composed of invited speakers chosen by a scientific organizing committee that includes former Proteoglycan Gordon Conference Chairs and others who have substantial research expertise proteoglycans research. In addition to assembling high level proteoglycan research scientists the conference provides a forum for new investigators to present their work in poster sessions or, in some cases, as invited speakers to give short talks that are intertwined between the core set of invited speakers. The Gordon conference setting provides a unique and effective way for all of the attendees to closely interact. The extended discussions as well as the well-organized pastoral setting at Proctor Academy gives attendees ample opportunity for direct interaction with speakers so they can gain additional insight into the latest research findings and, at the same, facilitate the formation of new collaborations. The proteoglycan field is well-known for its collegiality, open discussions, and support of junior investigators. Originally the conference focused primarily on cartilage and arthritis. However over time it became clear that proteoglycans have critical functions in numerous biological systems including the formation and pathology of many parts of the musculoskeletal system such as muscle, bone, tendons and teeth. In addition to their function in the skeleton the proteoglycans have fundamental roles in immunology and inflammation, vascularization, cardiac function, cancer and development. The roles of proteoglycans in these systems has provided a pivitol foundation for devising therapy to treat common diseases associated with them and these research areas will be the focus of the proposed conference. Proteoglycans have also been shown to have key roles in rare diseases such as multiple hereditary exostoses, and mucopolysaccaridosis both of which will highlighted in the program. This year two new sessions will be added that will address the role of proteoglycans in stem cell biology and tissue engineering and regenerative medicine (TERM). The Proteoglycan conference is very international with over 40% of the attendees coming from Europe, Asia, South American and Australia. Attendees will be selected by invitation from the applications submitted on- line and will be chosen to represent a diverse set of researchers and careful attention will be paid to the inclusion of women and underrepresented minorities in all aspects of the conference including Discussion Leaders, Speakers, Poster Presenters and Attendees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's Disease
  • 批准号:
    10054740
  • 项目类别:
  • 资助金额:
    $259.51万
  • 财政年份:
    2020
  • 负责人:
    ROBERT J LINHARDT
  • 依托单位:
Endothelial glycocalyx reconstitution during sepsis
  • 批准号:
    8803172
  • 项目类别:
  • 资助金额:
    $69.7万
  • 财政年份:
    2014
  • 负责人:
    ROBERT J LINHARDT
  • 依托单位:
Endothelial glycocalyx reconstitution during sepsis
  • 批准号:
    9278256
  • 项目类别:
  • 资助金额:
    $66.49万
  • 财政年份:
    2014
  • 负责人:
    ROBERT J LINHARDT
  • 依托单位:
Endothelial glycocalyx reconstitution during sepsis
  • 批准号:
    8927683
  • 项目类别:
  • 资助金额:
    $65.85万
  • 财政年份:
    2014
  • 负责人:
    ROBERT J LINHARDT
  • 依托单位:
海外基金